CPHI (STOCKS)
China Pharma Holdings, Inc.
$0.809900
+0.095300 (+13.34%)
Prev close: $0.714600
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Zhi Lin Li
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $31.17M
- Employees
- 231
- P/E (TTM)
- -1.39
- P/B (TTM)
- 0.78
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2011 (Q3)
|
$40.00 | $61.20 | -21.2000 | -34.64% |
|
Jun 2011 (Q2)
|
$60.00 | $56.10 | +3.9000 | +6.95% |
|
Mar 2011 (Q1)
|
$50.00 | $58.65 | -8.6500 | -14.75% |
|
Mar 2010 (Q4)
|
$75.00 | $79.90 | -4.9017 | -6.13% |
Financial Statements
| Revenues | $3.99M |
| Benefits Costs and Expenses | $7.54M |
| Cost Of Revenue | $3.70M |
| Costs And Expenses | $7.54M |
| Gross Profit | $289.60K |
| Nonoperating Income/Loss | $52.59K |
| Operating Expenses | $3.89M |
| Research and Development | $335.08K |
| Other Operating Expenses | $2.57M |
| Operating Income/Loss | -$3.60M |
| Income/Loss From Continuing Operations After Tax | -$3.55M |
| Income/Loss From Continuing Operations Before Tax | -$3.55M |
| Interest Expense, Operating | $29.54K |
| Net Income/Loss | -$3.55M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$3.55M |
| Net Income/Loss Available To Common Stockholders, Basic | -$3.55M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.54 |
| Diluted Earnings Per Share | -$0.54 |
| Basic Average Shares | 33,561,305 |
| Assets | $45.14M |
| Current Assets | $2.00M |
| Inventory | $1.50M |
| Prepaid Expenses | $74.28K |
| Other Current Assets | $430.78K |
| Noncurrent Assets | $43.14M |
| Fixed Assets | $4.30M |
| Intangible Assets | $38.67M |
| Other Non-current Assets | $161.88K |
| Liabilities | $8.12M |
| Current Liabilities | $7.27M |
| Noncurrent Liabilities | $851.92K |
| Equity | $37.02M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $37.02M |
| Liabilities And Equity | $45.14M |
| Net Cash Flow From Operating Activities | $166.65K |
| Net Cash Flow From Operating Activities, Continuing | $88.38K |
| Net Cash Flow From Investing Activities | $97.71K |
| Net Cash Flow From Investing Activities, Continuing | $55.69K |
| Net Cash Flow From Financing Activities | -$296.53K |
| Net Cash Flow From Financing Activities, Continuing | -$296.53K |
| Exchange Gains/Losses | -$35.40K |
| Net Cash Flow | -$25.56K |
| Net Cash Flow, Continuing | -$68.42K |
| Comprehensive Income/Loss | -$2.88M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$2.86M |
| Other Comprehensive Income/Loss | -$2.35M |